Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts that cover Nurix Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $29.08, which forecasts a 51.38% increase in the stock price over the next year. The lowest target is $16 and the highest is $36.

Price Target: $29.08 (+51.38%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$29.08	$30	$36
Change	-16.71%	+51.38%	+56.17%	+87.40%

Analyst Ratings

The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	7	7	5	6	6	6
Buy	7	7	7	6	5	6
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	14	14	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Terence Flynn Morgan Stanley	Morgan Stanley	Hold → Buy Upgrades $15 → $36	Hold → Buy	Upgrades	$15 → $36	+87.40%	Jan 8, 2026
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $21 → $30	Buy	Maintains	$21 → $30	+56.17%	Dec 16, 2025
Joseph Catanzaro Mizuho	Mizuho	Buy Maintains $24 → $30	Buy	Maintains	$24 → $30	+56.17%	Dec 10, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $28 → $31	Strong Buy	Maintains	$28 → $31	+61.37%	Dec 10, 2025
Jeet Mukherjee BTIG	BTIG	Strong Buy Maintains $27 → $30	Strong Buy	Maintains	$27 → $30	+56.17%	Dec 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

86.95M

Increased by 59.40%

from 54.55M

Revenue Next Year

56.97M

Decreased by -34.48%

from 86.95M

EPS This Year

-3.21

from -2.88

EPS Next Year

-3.35

from -3.21

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Nov 30, 2020	Nov 30, 2021	Nov 30, 2022	Nov 30, 2023	Nov 30, 2024	Nov 30, 2025	Nov 30, 2026
Revenue	17.82M	29.75M	38.63M	76.99M	54.55M	86.95M	56.97M
Revenue Growth	-42.73%	66.95%	29.84%	99.31%	-29.15%	59.40%	-34.48%
EPS	-2.76	-2.73	-3.71	-2.65	-2.88	-3.21	-3.35
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	19

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	114.2M	99.8M
Avg	87.0M	57.0M
Low	69.0M	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	109.4%	14.7%
Avg	59.4%	-34.5%
Low	26.5%	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-3.09	-2.24
Avg	-3.21	-3.35
Low	-3.32	-4.37

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.